Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)NCT05343455Journey Medical CorporationPhase 3Completed2023-06-30Actual
Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) DeficiencyNCT05345171RAREPhase 3Active not recruiting2027-09Estimated
Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade HemorrhoidsNCT05348200CTXRPhase 2Completed2023-04-20Actual
Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALSNCT05349721PTC TherapeuticsPhase 2Terminated2024-09-26Actual
Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPPNCT05352893Vanda PharmaceuticalsPhase 3Completed2023-08-17Actual
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe HypertriglyceridemiaNCT05355402IONSPhase 2Completed2023-03-22Actual
A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALSNCT05357950NRSNPhase 2Completed2023-11-02Actual
A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PDNCT05357989ANVSPhase 3Completed2023-12-04Actual
28-Day Study of SAGE-718 on Functioning Capacity in Participants With Huntington's DiseaseNCT05358821SUPNPhase 2Completed2024-02-29Actual
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular CarcinomaNCT05359861CHRSPhase 2Completed2025-06-30Actual
Evaluating the Effects of Tasimelteon in Individuals With Autism Spectrum Disorder (ASD) and Sleep DisturbancesNCT05361707Vanda PharmaceuticalsPhase 3Unknown2025-07Estimated
Administration of ARS-1 or Albuterol in Subjects With Persistent AsthmaNCT05363670SPRYPhase 2Completed2024-02-02Actual
Natrunix or Placebo in Combination With Methotrexate in Rheumatoid ArthritisNCT05363891XBITPhase 2Completed2024-10-31Actual
Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPPNCT05366855Vanda PharmaceuticalsPhase 3Terminated2024-07-12Actual
A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous UrticariaNCT05368285Celldex TherapeuticsPhase 2Completed2023-09-28Actual
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal AndrogensNCT05370521Spruce BiosciencesPhase 2Terminated2023-08-03Actual
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)NCT05371613DNLIPhase 2, Phase 3Active not recruiting2027-12Estimated
Phase 3 Boosting Study for the SARS-CoV-2 rS Variant VaccinesNCT05372588NovavaxPhase 3Completed2022-07-17Actual
A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive DisorderNCT05376150XENEPhase 2Completed2023-09-18Actual
PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell LymphomaNCT05380635SoligenixPhase 2Completed2022-08-16Actual
A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05NCT05387083TARSPhase 2Completed2024-06-26Actual
A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)NCT05392114IONSPhase 3Active not recruiting2026-12Estimated
A Study in Subjects With Retinitis PigmentosaNCT05392179ALDXPhase 2Completed2023-06-23Actual
A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic CoughNCT05392192ALDXPhase 2Completed2023-04-13Actual
Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)NCT05397470Fulcrum TherapeuticsPhase 3Terminated2024-11-19Actual
Ibrexafungerp for the Treatment of Complicated Vulvovaginal CandidiasisNCT05399641SCYXPhase 3Completed2023-05-16Actual
A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver FibrosisNCT05402371Hepion Pharmaceuticals, Inc.Phase 2Unknown2025-05Estimated
A Study of CDX-0159 in Patients With Chronic Inducible UrticariaNCT05405660Celldex TherapeuticsPhase 2Completed2024-06-12Actual
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsNCT05407064Definium Therapeutics US, Inc.Phase 2Completed2023-10-06Actual
Dazucorilant in Patients With Amyotrophic Lateral SclerosisNCT05407324Corcept TherapeuticsPhase 2Active not recruiting2026-10Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.